
Donald S. Shepard, PhD
Advertisement
Articles by Donald S. Shepard, PhD
Advertisement
Latest Updated Articles
The Employer's PerspectiveJanuary 1st 2001
Cost Effectiveness of Intensive Treatment of HypertensionDecember 1st 1998
Advertisement
Advertisement
Trending on AJMC
1
5 August FDA Approvals Marked by Novelty, Pushback
2
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
Cross-Trial Vitiligo Data: What Payers Can and Can't Compare
5